👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Arteris director Wayne Cantwell sells $50,093 in stock

Published 13/12/2024, 22:12
AIP
-

Wayne Cantwell, a director at Arteris, Inc. (NASDAQ:AIP), recently executed sales of the company's common stock totaling $50,093. The transactions occurred on December 11 and 12, 2024, involving 2,400 shares sold at a weighted average price of $10.0067 and 2,600 shares at an average of $10.0297, respectively. The sales come as the $401 million market cap company trades near its 52-week high, with the stock showing impressive momentum, gaining nearly 13% in the past week. These sales were conducted under a 10b5-1 trading plan, which Cantwell adopted earlier this year. Following these transactions, Cantwell holds 238,198 shares directly and an additional 38,761 shares indirectly through a 401K plan. The company maintains impressive gross profit margins of 89%. InvestingPro subscribers can access detailed insider trading patterns and 12 additional ProTips to better understand the company's financial health and market position.

In other recent news, Arteris Inc. delivered a strong performance in its Q3 2024 earnings call, reporting a record annual contract value (ACV) plus royalties of $60.5 million. The company witnessed an 11% year-over-year revenue increase to $14.7 million and a positive free cash flow of $1.1 million. The robust demand in the AI and automotive sectors is driving the company's growth.

Arteris also secured a significant deal with one of the top five global tech companies and is expanding into the microcontroller market. The company's new NoC Tiling product has received positive feedback, and bookings for Q3 and Q4 are expected to be strong.

Looking ahead, Arteris forecasts Q4 2024 ACV plus royalties to be between $63 million and $67 million, with full-year revenue projections for 2024 between $56.9 million and $57.9 million. Despite a non-GAAP net loss of $3.1 million for the quarter, the company anticipates continued positive free cash flow for three consecutive quarters. These recent developments suggest Arteris is well-positioned for future growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.